Erdafitinib (BALVERSA) 4MG tablets (56 tab BTL).
Ended Awarded Last action
- Contract number
- 36C26024F0421
- Awardee
-
Janssen Biotech Inc. UEI NVYMGFA53MN7
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $0
Award facts
- Contract value
- $0.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Carrollton, TX 75010, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$211,715 | |
| Original award | $211,715 |
About this award
This is a firm fixed price delivery order issued by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc., for the supply of the chemotherapy drug ERDAFITINIB (BALVERSA) 4MG TABLETS (56 TAB BTL). The order is placed against Janssen's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, which is a $3.1 billion multiple award schedule that allows VHA to procure prescription drugs for veteran healthcare programs. This particular delivery order has a potential value of $211,715.40 and a completion date of June 19, 2025. No set-aside designation was used for this contract award to the for-profit manufacturer Janssen Biotech Inc.
Quick answers
Who was awarded contract 36C26024F0421?
36C26024F0421 was awarded to Janssen Biotech Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on June 20, 2024.
How much is contract 36C26024F0421 worth?
The government has obligated $0 on 36C26024F0421.
Is contract 36C26024F0421 an order under another contract?
Yes. 36C26024F0421 is a delivery order under 36F79719D0217, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26024F0421 competed?
The extent of competition for 36C26024F0421 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award